🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lee Ainslie’s UTHR Holdings & Trades

First Buy
Q1 2015
Duration Held
19 Quarters
Largest Add
Q3 2019
+12,762 Shares
Current Position
1,219 Shares
$660,564 Value

Lee Ainslie's UTHR Position Overview

Lee Ainslie (via Maverick Capital LTD) currently holds 1,219 shares of United Therapeutics Corporation (UTHR) worth $660,564, representing 0.01% of the portfolio. First purchased in 2015-Q1, this medium-term investment has been held for 19 quarters.

Based on 13F filings, Lee Ainslie has maintained a strategic position in UTHR, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2019, adding 12,762 shares. Largest reduction occurred in Q3 2017, reducing 18,720 shares.

Analysis based on 13F filings available since 2013 Q2

Lee Ainslie's United Therapeutics Corporation (UTHR) Holding Value Over Time

Track share changes against reported price movement

Quarterly United Therapeutics Corporation (UTHR) Trades by Lee Ainslie

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +1,219 New Buy 1,219 $541.89
Q4 2021 -4,361 Sold Out 0 $0.00
Q3 2021 -3,992 Reduce 47.79% 4,361 $184.59
Q2 2021 +839 Add 11.17% 8,353 $179.46
Q1 2021 +7,514 New Buy 7,514 $167.29
Q1 2020 -14,781 Sold Out 0 $0.00
Q4 2019 +2,019 Add 15.82% 14,781 $88.09
Q3 2019 +12,762 New Buy 12,762 $79.77
Q3 2017 -18,720 Sold Out 0 $0.00
Q2 2017 -720 Reduce 3.70% 18,720 $129.75
Q1 2017 -6,770 Reduce 25.83% 19,440 $135.39
Q4 2016 +300 Add 1.16% 26,210 $143.42
Q3 2016 -800 Reduce 3.00% 25,910 $118.06
Q2 2016 +5,780 Add 27.62% 26,710 $105.92
Q1 2016 +10,360 Add 98.01% 20,930 $111.42
Q4 2015 +930 Add 9.65% 10,570 $156.58
Q3 2015 +5,870 Add 155.70% 9,640 $131.22
Q2 2015 -730 Reduce 16.22% 3,770 $174.01
Q1 2015 +4,500 New Buy 4,500 $172.44

Lee Ainslie's United Therapeutics Corporation Investment FAQs

Lee Ainslie first purchased United Therapeutics Corporation (UTHR) in Q1 2015, acquiring 4,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Lee Ainslie has held United Therapeutics Corporation (UTHR) for 19 quarters since Q1 2015.

Lee Ainslie's largest addition to United Therapeutics Corporation (UTHR) was in Q3 2019, adding 12,762 shares worth $1.02 M.

According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 1,219 shares of United Therapeutics Corporation (UTHR), valued at approximately $660,564.

As of the Q3 2026 filing, United Therapeutics Corporation (UTHR) represents approximately 0.01% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.

Lee Ainslie's peak holding in United Therapeutics Corporation (UTHR) was 26,710 shares, as reported at the end of Q2 2016.